A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Jolicœur, E Marc ^a   Banai, Shmuel ^b   Henry, Timothy D ^c   Schwartz, Marc ^d   Doucet, Serge ^a   White, Christopher J ^e   Edelman, Elazer ^f,g   Verheye, Stefan ^h  

^a MONTREAL HEART INSTITUTE   (Canada)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d Neovasc Inc   (Canada)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h ZNA Middelheim Hospital   (Belgium)

Author keywords

Advanced coronary artery disease; Angina; Coronary sinus; Myocardial ischemia; Reducer; Refractory angina

Indexed keywords

DOBUTAMINE;

ADULT; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY SINUS; CORONARY SINUS REDUCER; DEVICE SAFETY; DEVICE THERAPY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ST SEGMENT DEPRESSION;

ANGINA, STABLE; CANADA; CARDIAC CATHETERIZATION; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CLINICAL PROTOCOLS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY SINUS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ECHOCARDIOGRAPHY, STRESS; EQUIPMENT DESIGN; EUROPE; HUMANS; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH DESIGN; STROKE VOLUME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84875056490     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-46     Document Type: Article

References (28)

1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003, 41:159-168.
2. Jolicoeur EM, Granger CB, Henry TD, Stockbridge N, Smith S, Mark D, Califf RM, Henry TD, Chaitman BR, Granger CB, Working Group Members Clinical and research issues regarding chronic advanced coronary artery disease: part I: contemporary and emerging therapies. Am Heart J 2008, 155:418-434. 10.1016/j.ahj.2007.12.004, 18294474, Working Group Members.
3. Williams B, Menon M, Satran D, Hayward D, Hodges JS, Burke MN, Johnson RK, Poulose AK, Traverse JH, Henry TD. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Catheter Cardiovasc Interv 2010, 75:886-891.
4. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis-how many patients might be eligible?. Am J Cardiol 1999, 84:A8-A600.
5. Paz Y, Shinfeld A. Mild increase in coronary sinus pressure with coronary sinus reducer stent for treatment of refractory angina. Nat Clin Pract Cardiovasc Med 2009, 6:E3. 10.1038/ncpcardio1475, 19234494.
6. Beck CS, Leighninger DS. Operations for coronary artery disease. J Am Med Assoc 1954, 156:1226-1233. 10.1001/jama.1954.02950130006002, 13211223.
7. Beck CS, Leighninger DS. Scientific basis for the surgical treatment of coronary artery disease. J Am Med Assoc 1955, 159:1264-1271. 10.1001/jama.1955.02960300008003, 13271060.
8. Sandler G, Slesser BV, Lawson CW. The Beck operation in the treatment of angina pectoris. Thorax 1967, 22:34-37. 10.1136/thx.22.1.34, 471586, 4961992.
9. Wising PJ. The Beck-I operation for angina pectoris: medical aspects. Acta Med Scand 1963, 174:93-98.
10. Brofman BL. Medical evaluation of the Beck operation for coronary artery disease. J Am Med Assoc 1956, 162:1603-1606. 10.1001/jama.1956.02970350019005, 13376326.
11. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840. 10.1056/NEJMra061889, 17314342.
12. Ido A, Hasebe N, Matsuhashi H, Kikuchi K. Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia. Am J Physiol Heart Circ Physiol 2001, 280:H1361-H1367.
13. Banai S, Ben MS, Parikh KH, Medina A, Sievert H, Seth A, Tsehori J, Paz Y, Sheinfeld A, Keren G. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol 2007, 49:1783-1789. 10.1016/j.jacc.2007.01.061, 17466229.
14. Banai S, Schwart M, Sievert H, Seth A, Keren G, Parikh KH. Long-term follow-up to evaluate the safety of the neovasc reducer, a device-based therapy for chronic refractory angina. J Am Coll Cardiol 2010, 55:A98.E927.
15. McGillion M, Arthur HM, Cook A, Carroll SL, Victor JC, L'allier PL, Jolicoeur EM, Svorkdal N, Niznick J, Teoh K, Cosman T, Sessle B, Watt-Watson J, Clark A, Taenzer P, Coyte P, Malysh L, Galte C, Stone J. Management of patients with refractory angina: Canadian cardiovascular society/Canadian pain society joint guidelines. Can J Cardiol 2012, Suppl 2:S20-S41.
16. Jolicoeur EM, Cartier R, Henry TD, Barsness GW, Bourassa MG, McGillion M, L'Allier PL. Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification. Can J Cardiol 2012, Suppl 2:S50-S59.
17. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001, 134:657-662.
18. Chaitman BR, Stone PH, Knatterud GL, Forman SA, Sopko G, Bourassa MG, Pratt C, Rogers WJ, Pepine CJ, Conti CR, The ACIP Investigators Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. J Am Coll Cardiol 1995, 26:585-593. 10.1016/0735-1097(95)00013-T, 7642847, The ACIP Investigators.
19. Frolicher VF, Myers J. Manual of Exercise Testing 3rd edition 2007, Philadelphia: Mosby Elsevier.
20. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn. Development and evaluation of the Seattle Angina questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995, 25:333-341. 10.1016/0735-1097(94)00397-9, 7829785.
21. Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation 2003, 108:2219-2223. 10.1161/01.CIR.0000095271.08248.EA, 14557359.
22. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA, ACT34-CMI Investigators Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011, 109:428-436. 10.1161/CIRCRESAHA.111.245993, 3190575, 21737787, ACT34-CMI Investigators.
23. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001, 323:1123-1124. 10.1136/bmj.323.7321.1123, 1121605, 11701584.
24. Knoke JD. Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error. Biometrics 1991, 47:523-533. 10.2307/2532143, 1912259.
25. Von LM. The venous drainage of the human myocardium. Adv Anat Embryol Cell Biol 2003, 168:1-104.
26. Parmar RC, Kulkarni S, Nayar S, Shivaraman A. Coronary sinus thrombosis. J Postgrad Med 2002, 48:312-313.
27. Neri E, Tripodi A, Tucci E, Capannini G, Sassi C. Dramatic improvement of LV function after coronary sinus thromboembolectomy. Ann Thorac Surg 2000, 70:961-963. 10.1016/S0003-4975(00)01639-8, 11016343.
28. Jolicoeur EM, Ohman EM, Temple R, Swain J, Stockbridge N, Witten C, Smith S, Mark D, Califf RM, Henry TD, Chaitman BR, Granger CB. Clinical and research issues regarding chronic advanced coronary artery disease part II: trial design, outcomes, and regulatory issues. Am Heart J 2008, 155:435-444. 10.1016/j.ahj.2007.12.005, 18294475.